School of Medicine
Showing 21-30 of 125 Results
-
Dr. Qiwen Deng
Postdoctoral Scholar, Pathology
BioMy research aims to understand how immune–stromal interactions shape tissue injury, repair, and fibrosis across chronic diseases. I combine multiplexed spatial proteomics (CODEX), single-cell and spatial transcriptomics, and molecular pathology approaches to dissect the organization and function of complex tissue microenvironments. By mapping spatially resolved cellular neighborhoods in human biopsies, I seek to uncover conserved and disease-specific patterns that can guide biomarker discovery and therapeutic development.
Working within a laboratory focused on the mechanisms and therapeutic targeting of fibrotic diseases, I investigate chronic kidney disease alongside other models of organ fibrosis. With a background spanning molecular biology, therapeutic development, and spatial biology, I aim to advance studies that connect detailed tissue analysis with potential clinical applications. I welcome opportunities for collaborative research in chronic kidney disease and other fibrosis-related conditions. -
Ifeanyichukwu Emmanuel Eke
Postdoctoral Scholar, Pathology
BioI am a chemical biologist with a broad interest in defining the mechanisms-of-action of novel compounds that can be used as potential drugs or diagnostic probes for different bacterial and viral infections. In addition to my flair for research, I am passionate about teaching, mentorship, leadership, and entrepreneurship.
-
Jelle Folkerts
Postdoctoral Scholar, Pathology
BioDr. Folkerts received his master's degree in Drug Innovation from Utrecht University in the Netherlands, during which he spent a year at the Galli lab at Stanford on a Fulbright Scholarship. During this time, Dr. Folkerts played a key role in developing a technology platform employing functional genomics and high-resolution single-cell confocal imaging, enabling the rapid identification of degranulation regulators in primary human mast cells. Following his time at Stanford, Dr. Folkerts studied the regulatory mechanisms of human mast cell activation under the guidance of Rudi Hendriks and Marcus Maurer, earning his Ph.D. in 2022. He then returned to Stanford as a postdoctoral fellow in the Galli lab, where his current research focuses on the identification of human mast cell degranulation regulators using a whole-genome CRISPR knockout library screen, and the validation of these findings using the recently developed technology platform. It is his long-standing goal to contribute to the design and development of specific and effective therapeutic interventions for mast cell-mediated diseases.
